CRUTCHFIELD BRADFORD
Known title: Chief Commercial OfficerCIK: 0001246406
CRUTCHFIELD BRADFORD's purchase track record
CRUTCHFIELD BRADFORD has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/13/2022 | TXG | $6K | +1.3% | -13.3% | -0.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| TXG | ▼ Sell | Open Market | 286 | $14K | 5/23/2022 | View on chart |
| TXG | ▲ Buy | Open Market | 158 | $6K | 5/13/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 288 | $23K | 2/22/2022 | View on chart |
| TXG | ▲ Buy | Option Exercise | 17,000 | $20K | 2/15/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 17,000 | $1.6M | 2/15/2022 | View on chart |
| TXG | ▲ Buy | Option Exercise | 17,000 | $20K | 1/12/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 6,195 | $728K | 1/12/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 5,185 | $613K | 1/12/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 1,017 | $121K | 1/12/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 3,200 | $390K | 1/12/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 100 | $12K | 1/12/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 100 | $12K | 1/12/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 100 | $12K | 1/12/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 3 | $375 | 1/12/2022 | View on chart |
| TXG | ▼ Sell | Open Market | 1,100 | $133K | 1/12/2022 | View on chart |
| TXG | ▲ Buy | Option Exercise | 49,910 | $252K | 12/21/2021 | View on chart |
| TXG | ▲ Buy | Option Exercise | 4,688 | $6K | 12/21/2021 | View on chart |
| TXG | ▲ Buy | Option Exercise | 17,000 | $20K | 12/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 100 | $14K | 12/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 1,565 | $215K | 12/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 3,235 | $448K | 12/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 9,599 | $1.3M | 12/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 800 | $113K | 12/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 1,701 | $239K | 12/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 281 | $42K | 11/22/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 1,030 | $168K | 11/12/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 4,122 | $677K | 11/12/2021 | View on chart |
| TXG | ▲ Buy | Option Exercise | 17,000 | $20K | 11/12/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 6,872 | $1.1M | 11/12/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 4,776 | $792K | 11/12/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 100 | $17K | 11/12/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 100 | $17K | 11/12/2021 | View on chart |
| TXG | ▲ Buy | Option Exercise | 17,000 | $20K | 10/12/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 3,043 | $483K | 10/12/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 7,997 | $1.3M | 10/12/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 5,960 | $933K | 10/12/2021 | View on chart |
| TXG | ▲ Buy | Option Exercise | 17,000 | $20K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 2,300 | $389K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 300 | $51K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 400 | $69K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 2,694 | $472K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 3,906 | $688K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 1,000 | $178K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 500 | $89K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 100 | $18K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 100 | $18K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 1,700 | $301K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 2,700 | $470K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 1,300 | $221K | 9/13/2021 | View on chart |
| TXG | ▼ Sell | Open Market | 270 | $44K | 8/23/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
10x Genomics Partners With Fred Hutchinson Cancer Center
10x Genomics announced a new collaboration with the Fred Hutchinson Cancer Center to apply single-cell and spatial technologies to solid tumors and blood cancers. This partnership aims to advance research in hematologic malignancies. Separately, Barclays raised its price target for the stock to $110, reflecting continued analyst interest in the company's growth potential.
10x Genomics Partners With Fred Hutchinson Cancer Center. 10x Genomics announced a new collaboration with the Fred Hutchinson Cancer Center to apply single-cell and spatial technologies to solid tumors and blood cancers. This partnership aims to advance research in hematologic malignancies. Separately, Barclays raised its price target for the stock to $110, reflecting continued analyst interest in the company's growth potential.